Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
Teradata Corp
TDC
eBay
EBAY
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 14.225
- -0.295-2.03%
Trading Jan 6 15:45 ET
366.69MMarket Cap-12.67P/E (TTM)
15.250High14.150Low47.05KVolume14.400Open14.520Pre Close675.89KTurnover0.36%Turnover Ratio1293.18P/E (Static)25.78MShares22.00052wk High1.74P/B186.77MFloat Cap12.33052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM7.58%Amplitude12.330Historical Low14.364Avg Price1Lot Size
Contineum Therapeutics Key Stats
EPS
According to the latest financial report of Contineum Therapeutics, the latest earnings per share (TTM) for the company is -0.40. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Contineum Therapeutics's free cash flow? The latest report shows it as -6.25M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Contineum Therapeutics shows that the company's current ratio is 37.06, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Contineum Therapeutics, the quick ratio is 36.84, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Contineum Therapeutics? The latest ROE figure is -4.80%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Contineum Therapeutics, the total asset return on investment (ROA) is -4.69%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Contineum Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Contineum Therapeutics, the net profit margin is 83.13%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...